Loading publications…
The last 5 uploaded publications
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C. Owen, Xue Bai, Gaik Tin Quah, Serigne Lo, Clara Allayous, Sophia Callaghan, Clara Martínez-Vila, Roslyn Wallace, Prachi Bhave, Irene L. M. Reijers, Nicola Thompson, Vito Vanella, Camille L. Gérard, Sandrine Aspeslagh, Alice Labianca, Adnan Khattak, Mario Mandalà, Wen Xu, Bart Neyns, Olivier Michielin, Christian U. Blank, Sarah J. Welsh, Andrew Haydon, Shahneen Sandhu, Joanna Mangana, Jennifer L. McQuade, Paolo A. Ascierto, Lisa Zimmer, Douglas B. Johnson, Ana Arance, Paul Lorigan, Célèste Lebbé, Matteo S. Carlino, Ryan J. Sullivan, Georgina V. Long, Alexander M. Menzies (2021). Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. , 32(7), DOI: https://doi.org/10.1016/j.annonc.2021.03.204.
Article62 days agoDelayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C. Owen, Xue Bai, Gaik Tin Quah, Serigne Lo, Clara Allayous, Sophia Callaghan, Clara Martínez-Vila, Roslyn Wallace, Prachi Bhave, Irene L. M. Reijers, Nicola Thompson, Vito Vanella, Camille L. Gérard, Sandrine Aspeslagh, Alice Labianca, Adnan Khattak, Mario Mandalà, Wen Xu, Bart Neyns, Olivier Michielin, Christian U. Blank, Sarah J. Welsh, Andrew Haydon, Shahneen Sandhu, Joanna Mangana, Jennifer L. McQuade, Paolo A. Ascierto, Lisa Zimmer, Douglas B. Johnson, Ana Arance, Paul Lorigan, Célèste Lebbé, Matteo S. Carlino, Ryan J. Sullivan, Georgina V. Long, Alexander M. Menzies (2021). Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. , 32(7), DOI: https://doi.org/10.1016/j.annonc.2021.03.204.
Article62 days agoSingle-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
Florentia Dimitriou, Kenjiro Namikawa, Irene L. M. Reijers, Elizabeth I. Buchbinder, J. Soon, Anne Zaremba, Paweł Teterycz, Meghan J. Mooradian, Emma Armstrong, Yasuhiro Nakamura, Maria Grazia Vitale, Lena Tran, Xue Bai, Clara Allayous, S. Provent-Roy, Alice Indini, Prachi Bhave, Mohamad Farid, Katharina C. Kähler, Inderjit Mehmi, Victoria Atkinson, Oliver Klein, Connor J. Stonesifer, Farzana Y. Zaman, Andrew Haydon, Richard D. Carvajal, Omid Hamid, Reinhard Dummer, Axel Hauschild, Matteo S. Carlino, Mario Mandalà, Caroline Robert, Célèste Lebbé, Jun Guo, Douglas B. Johnson, Paolo A. Ascierto, Alexander N. Shoushtari, Ryan J. Sullivan, Bożena Cybulska-Stopa, Piotr Rutkowski, Lisa Zimmer, Shahneen Sandhu, Christian U. Blank, Serigne Lo, Alexander M. Menzies, Georgina V. Long (2022). Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study. , 33(9), DOI: https://doi.org/10.1016/j.annonc.2022.06.004.
Article62 days agoDelayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C. Owen, Xue Bai, Gaik Tin Quah, Serigne Lo, Clara Allayous, Sophia Callaghan, Clara Martínez-Vila, Roslyn Wallace, Prachi Bhave, Irene L. M. Reijers, Nicola Thompson, Vito Vanella, Camille L. Gérard, Sandrine Aspeslagh, Alice Labianca, Adnan Khattak, Mario Mandalà, Wen Xu, Bart Neyns, Olivier Michielin, Christian U. Blank, Sarah J. Welsh, Andrew Haydon, Shahneen Sandhu, Joanna Mangana, Jennifer L. McQuade, Paolo A. Ascierto, Lisa Zimmer, Douglas B. Johnson, Ana Arance, Paul Lorigan, Célèste Lebbé, Matteo S. Carlino, Ryan J. Sullivan, Georgina V. Long, Alexander M. Menzies (2021). Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. , 32(7), DOI: https://doi.org/10.1016/j.annonc.2021.03.204.
Article62 days ago1138P Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy
C. Owen, Xue Bai, Thuan Chong Quah, Serigne Lo, Sophia Callaghan, Clara Martínez-Vila, Prachi Bhave, Irene L. M. Reijers, Camille L. Gérard, S. Aspelagh, Wen Xu, Sarah J. Welsh, Shahneen Sandhu, Joanna Mangana, Jennifer L. McQuade, Paolo A. Ascierto, Lisa Zimmer, Douglas B. Johnson, Célèste Lebbé, Alexander M. Menzies (2020). 1138P Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy. , 31, DOI: https://doi.org/10.1016/j.annonc.2020.08.1261.
Article62 days ago